XML 32 R18.htm IDEA: XBRL DOCUMENT v3.25.1

ACCRUED EXPENSES

9 Months Ended

Mar. 31, 2025

ACCRUED EXPENSES

ACCRUED EXPENSES

(11) ACCRUED EXPENSES

Accrued expenses consist of the following:

		March 31,				June 30,
		2025				2024
Clinical / regulatory costs		$	378,592			$	1,509,797
Other research related expenses			40,509				65,972
Professional Services			55,040				284,215
Personnel costs			-				1,771,694
Selling expenses			-				351,485
Other			32,319				201,883
		$	506,460			$	4,185,046

X

- Definition

The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 720
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483384/720-30-45-1

+ Details

Name:	us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration